Evidence map›Paper›PMID 34257627›Full record

ArticleContrast media & molecular imaging2021

Inflammation during Lung Cancer Progression and Ethyl Pyruvate Treatment Observed by Pulmonary Functional Hyperpolarized

Atsuomi Kimura, Seiya Utsumi, Akihiro Shimokawa, Renya Nishimori, Neil J Stewart, Yoshihiro Kamada, Hirohiko Imai, Hideaki Fujiwara

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Contrast media & molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Atsuomi KimuraDepartment of Medical Physics and Engineering, Area of Medical Imaging Technology and Science, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.ORCID 0000-0001-5702-276X
Seiya UtsumiDepartment of Medical Physics and Engineering, Area of Medical Imaging Technology and Science, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.
Akihiro ShimokawaDepartment of Medical Physics and Engineering, Area of Medical Imaging Technology and Science, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.
Renya NishimoriDepartment of Medical Physics and Engineering, Area of Medical Imaging Technology and Science, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.
Neil J StewartPOLARIS Imaging Sciences, Department of Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, UK.
Yoshihiro KamadaDepartment of Advanced Metabolic Hepatology, Graduate School of Medicine, Osaka University, Osaka, Japan.ORCID 0000-0001-5485-902X
Hirohiko ImaiDivision of Systems Informatics, Department of Systems Science, Graduate School of Informatics, Kyoto University, Kyoto, Japan.
Hideaki FujiwaraDepartment of Medical Physics and Engineering, Area of Medical Imaging Technology and Science, Division of Health Sciences, Graduate School of Medicine, Osaka University, Osaka, Japan.
The University of Osaka · JPKyoto University · JPUniversity of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the suitability of hyperpolarized

Indexed as

AnimalsCarcinogensInflammationLung NeoplasmsMagnetic Resonance ImagingMaleMicePyruvatesUrethaneXenonCarcinogensethyl pyruvatePyruvatesUrethaneXenon

Identifiers

PMID34257627
PMCPMC8261185
OpenAlexW3177252795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.